PneumaCare

Apologies as our site is still under construction and may still be missing some information. Please contact PneumaCare directly with any questions.

The Next Generation of Lung Function Imaging
and Assessment Technology


PneumaCare's lung function imaging devices are a revolutionary advancement in respiratory assessment that allows clinicians to rapidly identify pulmonary related issues, across a broader patient population, earlier in the patient care lifecycle. Using PneumaCare's proprietary SLP technology, the PneumaScan and Thora-3DI can capture functional images of the lungs, by analysing chest wall movement, and translate this data into pulmonary function outputs. This can all be done without any physical contact with the patient or the need to subject them to radiological or resonance treatments.

Respiratory Assessment
View Respiratory Area

The PneumaScan and Thora-3DI measure lung function in a non-contact non-invasive process, enabling a broader patient population to be assessed. As there is no need for disposables or daily calibration, the imaging can be done in a lung function lab, at the patient's bedside or even at a clinical facility admissions point. The results are presented in familiar formats along with advanced regional lung performance data and videos.

Thoracic Surgery
View Thoracic Area

The Thora-3DI provides detailed lung function data obtained from a non-contact, non-invasive measurement. The data provided can be viewed in traditional pulmonary function outputs and also allows the clinician to view regional pulmonary contributions and breathing phase symmetries. This information allows for pre-operation performance baseline establishment, and post-surgical recovery trending.

PneumaCare

PneumaCare's mantra is 'requirement drives innovation'. We design, from inspiration to product, in partnership with the clinical user, providing clinicians with novel observation platforms; beyond measurement to perception and insight.

Latest News

Pneumacare has been chosen from over 2100 international competitors as one of the 'top 50 emerging companies'.

PneumaCare Limited announces the appointment of Eric Stewart as Commercial Director

PneumaCare has received a new funding to help it develop a monitoring device for sufferers of chronic obstructive pulmonary disease to use at home.

View All

Events:

PneumaCare will be attending ERS 2012 September 1-5 in Vienna Austria

PneumaCare will be at ATS 2012 May 20-23 in San Francisco USA Booth 1408

Clement Clarke will now distribute PneumaCare Products in the UK/IRE markets from May 2012

Thora-3DI™ has begun its first clinical trial application at Heartlands Hospital in the UK

Thora-3DI™ received its CE approval April 2012